Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Low concern for cancer in humans for 6-chlorohexyl methacrylate (6-CHMA) should be assumed based on data for similar substances belong to the category "short chain alkyl methacrylates".

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Low concernfor cancer in humansof 6-chlorohexyl methacrylate (6-CHMA) should be assumed based on its similarity with short chain alkyl methacrylates.

No classification for carcinogenicity of 6-chlorohexyl methacrylate (6-CHMA)is proposed according to the CLP Regulation (EC n.1272/2008).

Additional information

No carcinogenicity studies have been conducted on 6-chlorohexyl methacrylate (6-CHMA) and on the similar substances belong to the category "short chain alkyl methacrylates" (see document "Read -across hypothesis and justification" in section 13 of this IUCLID dossier).

In SIDS Dossier of " Short chain alkyl methacrylates" approved at SIAM 18 (20-23 April 2004) this general consideration is reported: "None of the esters are genotoxic in in-vitro­or in-vivo assays. No epidemiological (cancer mortality) studies have been reported in the literature on any members of the category. Several cancer mortality studies have been reported on the reference chemical, methyl methacrylates (MMA, CAS 80-62-6), and these, together with the negative genotoxicity and cancer bioassays in rodents, indicate a low concern for cancer in humans".